Medicament classification prevails for White Petroleum Jelly I.P. under a drugs-and-medicines entry, displacing cosmetic treatment and interest.

White Petroleum Jelly I.P. manufactured under a valid drug licence was treated as a medicament for VAT classification because its essential character, functional use, and specific statutory coverage under the drugs-and-medicines entry prevailed over any broader cosmetic or residuary entry. The classification authority was criticised for relying on over-the-counter sale, absence of prescription, and the seller's business profile, since those factors did not displace the product's therapeutic or protective character or the binding precedent on medicament classification. Once the product fell within the concessional drugs-and-medicines entry, the basis for the higher tax demand disappeared and interest linked to that differential demand was also not leviable.

---

---

Issues: (i) Whether White Petroleum Jelly I.P. manufactured and sold under a valid drug licence is classifiable as "Drugs and Medicines" under Entry 19A, Part II, Schedule II of the M.P. VAT Act, 2002; (ii) whether the Appellate Board was justified in treating the product as a cosmetic and in not following the decision in Ponds India; (iii) whether interest under Section 18(1)(a) of the M.P. VAT Act, 2002 was leviable.

Issue (i): Whether White Petroleum Jelly I.P. manufactured and sold under a valid drug licence is classifiable as "Drugs and Medicines" under Entry 19A, Part II, Schedule II of the M.P. VAT Act, 2002.

Analysis: The product was found to be a non-perfumed White Petroleum Jelly I.P. containing light liquid paraffin IP grade and manufactured under a drug licence. The classification exercise turned on the essential character of the product, its functional use, and the statutory entry applicable to goods with therapeutic or protective value. The Court noted that the product was not a beautification article and that the specific entry for drugs and medicines expressly covered medicated ointments produced under drug licence and light liquid paraffin of IP grade. In such a situation, a specific entry could not be displaced by a broader cosmetic or residuary entry.

Conclusion: The product is classifiable under Entry 19A, Part II, Schedule II of the M.P. VAT Act, 2002 and not as a cosmetic.

Issue (ii): Whether the Appellate Board was justified in treating the product as a cosmetic and in not following the decision in Ponds India.

Analysis: The Court held that the factual and legal position governing White Petroleum Jelly I.P. was already covered by binding authority recognising the product as a medicament when manufactured under a drug licence and used for protective or curative purposes. The Board erred in relying on the product's availability over the counter, absence of prescription, and the appellant's broader business profile, because those factors did not outweigh the product's essential character and the specific statutory entry. The reasoning adopted by the Board was therefore inconsistent with the governing classification principles.

Conclusion: The Appellate Board was not justified in classifying the product as a cosmetic or in disregarding the binding precedent.

Issue (iii): Whether interest under Section 18(1)(a) of the M.P. VAT Act, 2002 was leviable.

Analysis: Once the product was held to be taxable under the concessional drug and medicine entry, the foundation for the differential demand and the consequential levy of interest did not survive. The interest levy was dependent upon the Revenue's higher-tax classification, which was rejected.

Conclusion: Interest under Section 18(1)(a) of the M.P. VAT Act, 2002 was not leviable.

Final Conclusion: The impugned classification orders were set aside, the product was held to fall under the drugs and medicines entry, and the consequential tax and interest demands did not survive.

Ratio Decidendi: Where a product's essential character and functional use place it within a specific drugs-and-medicines entry, that specific classification prevails over a cosmetic or residuary entry, and the absence of a prescription or over-the-counter sale does not by itself displace medicament classification.

---